We use cookies, including third-party cookies from Google to serve personalized ads through AdSense, to operate this site and understand how it is used. By continuing to browse, you accept this use. See our Privacy Policy and Terms of Use for details, including how to opt out of personalized advertising.
Accept
Health Works CollectiveHealth Works CollectiveHealth Works Collective
  • Health
    • Mental Health
  • Policy and Law
    • Global Healthcare
    • Medical Ethics
  • Medical Innovations
  • News
  • Wellness
  • Tech
Search
© 2023 HealthWorks Collective. All Rights Reserved.
Reading: Will Washington Prevent a Cure for Cancer?
Share
Notification Show More
Font ResizerAa
Health Works CollectiveHealth Works Collective
Font ResizerAa
Search
Follow US
  • About
  • Contact
  • Privacy
© 2023 HealthWorks Collective. All Rights Reserved.
Health Works Collective > Policy & Law > Health Reform > Will Washington Prevent a Cure for Cancer?
Health Reform

Will Washington Prevent a Cure for Cancer?

JohnCGoodman
JohnCGoodman
Share
2 Min Read
SHARE

The United States can rightly claim the title of medicine chest to the world. Almost two-thirds of research on new medicines approved in the last 10 years was performed in this country. Today, the U.S. accounts for 82% of the biotechnology research and development in the world and has over 2,900 medicines in the pipeline. U.S. biopharmaceutical exports rose to $46 billion in 2009 from $29 billion in 2005. [Yet] there are two big public-policy threats on the horizon for Merck … the biopharmaceutical industry.

The United States can rightly claim the title of medicine chest to the world. Almost two-thirds of research on new medicines approved in the last 10 years was performed in this country. Today, the U.S. accounts for 82% of the biotechnology research and development in the world and has over 2,900 medicines in the pipeline. U.S. biopharmaceutical exports rose to $46 billion in 2009 from $29 billion in 2005. [Yet] there are two big public-policy threats on the horizon for Merck … the biopharmaceutical industry. One is the Independent Payment Advisory Board, or IPAB, which originated in last year’s health-reform law. This board has the power to reduce Medicare payments for innovative products simply because overall Medicare costs exceed certain budget targets in any one year. The other harmful proposal on Washington’s agenda would impose price controls for the first time on the Medicare Part D prescription-drug program.

See article on U.S. government regulations that halter medical progress.

   

More Read

Value-based care: can we get there with current tools?
Status Update on Reform Law’s Temporary High Risk Pools
How Hospital Marketing Fits Into the Physician Quality Reporting System
Does Papa John’s Have a Legitimate Gripe About the Affordable Care Act?
ObamaCare and Jobs
TAGGED:healthcare reformIPABMedicare
Share This Article
Facebook Copy Link Print
Share

Stay Connected

1.5KFollowersLike
4.5KFollowersFollow
2.8KFollowersPin
136KSubscribersSubscribe

Latest News

Flat editorial illustration: Healthcare volunteer communication as a two-way, coordinator-supported process for confirming schedu
How to Manage Volunteer Communication in Healthcare: 5 Tactical Steps and Software Options
Global Healthcare
November 18, 2026
The Nervous System Reset Guide: Simple Ways To Manage Stress -- AI-generated illustration
The Nervous System Reset Guide: Simple Ways To Manage Stress
Infographics Mental Health
November 14, 2026
Flat editorial illustration: A single digital quality-management platform connects document control, electronic approval, audit r
6 Best QMS Software Platforms for ISO 13485 and FDA Part 820 (QMSR)
Global Healthcare Policy & Law
November 12, 2026
Flat editorial illustration: Healthcare editorial illustration about accurate patient intake connecting registration, clinical re
The Role of Patient Data Accuracy in Healthcare Operations
Global Healthcare Policy & Law
November 11, 2026

You Might also Like

Reasons to Reform Medicaid

November 9, 2011

Why ACOs Might Not Make an Impact (transcript)

April 11, 2011

Who Will Save the Independent Physicians?

February 2, 2013

Health Wonk Review: Sardonic Edition

May 24, 2013
Subscribe
Subscribe to our newsletter to get our newest articles instantly!
Follow US
© 2008-2026 HealthWorks Collective. All Rights Reserved.
  • About
  • Contact
  • Privacy
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?